115 related articles for article (PubMed ID: 8668934)
1. Direct DNA immunization of mice with plasmid DNA encoding the tegument protein pp65 (ppUL83) of human cytomegalovirus induces high levels of circulating antibody to the encoded protein.
Pande H; Campo K; Tanamachi B; Forman SJ; Zaia JA
Scand J Infect Dis Suppl; 1995; 99():117-20. PubMed ID: 8668934
[TBL] [Abstract][Full Text] [Related]
2. [VP22 enhances the immunological activity of human cytomegalovirus pp65 DNA vaccine: experimental study with mice].
Ma DX; Yu XP; Zhang XM; Zhou YB; Li Y; Jia JH; Zhao WM
Zhonghua Yi Xue Za Zhi; 2005 Apr; 85(15):1049-52. PubMed ID: 16029549
[TBL] [Abstract][Full Text] [Related]
3. [Construction and transfection of eucaryotic expression recombinant vector containing truncated region of UL83 gene of human cytomegalovirus and it's sheltered effect as DNA vaccine].
Gao RB; Li YQ; Wang ML
Wei Sheng Wu Xue Bao; 2006 Jun; 46(3):451-5. PubMed ID: 16933619
[TBL] [Abstract][Full Text] [Related]
4. Use of a lentiviral vector encoding a HCMV-chimeric IE1-pp65 protein for epitope identification in HLA-Transgenic mice and for ex vivo stimulation and expansion of CD8(+) cytotoxic T cells from human peripheral blood cells.
Rohrlich PS; Cardinaud S; Lulè J; Montero-Julian FA; Prodhomme V; Firat H; Davignon JL; Perret E; Monseaux S; Necker A; Michelson S; Lemonnier FA; Charneau P; Davrinche C
Hum Immunol; 2004 May; 65(5):514-22. PubMed ID: 15172452
[TBL] [Abstract][Full Text] [Related]
5. Suppression of murine cytomegalovirus (MCMV) replication with a DNA vaccine encoding MCMV M84 (a homolog of human cytomegalovirus pp65).
Morello CS; Cranmer LD; Spector DH
J Virol; 2000 Apr; 74(8):3696-708. PubMed ID: 10729145
[TBL] [Abstract][Full Text] [Related]
6. A canarypox vector-expressing cytomegalovirus (CMV) phosphoprotein 65 induces long-lasting cytotoxic T cell responses in human CMV-seronegative subjects.
Berencsi K; Gyulai Z; Gönczöl E; Pincus S; Cox WI; Michelson S; Kari L; Meric C; Cadoz M; Zahradnik J; Starr S; Plotkin S
J Infect Dis; 2001 Apr; 183(8):1171-9. PubMed ID: 11262198
[TBL] [Abstract][Full Text] [Related]
7. Expression of tegument protein pp65 of human cytomegalovirus (CMV) and its application to the analysis of viral-specific cellular immunity in CMV-infected individuals.
Tanaka N; Kimura H; Hoshino Y; Nishikawa K; Kojima S; Nishiyama Y; Morishima T
Arch Virol; 2002 Dec; 147(12):2405-17. PubMed ID: 12491106
[TBL] [Abstract][Full Text] [Related]
8. Induction of human cytomegalovirus (HCMV)-glycoprotein B (gB)-specific neutralizing antibody and phosphoprotein 65 (pp65)-specific cytotoxic T lymphocyte responses by naked DNA immunization.
Endresz V; Kari L; Berencsi K; Kari C; Gyulai Z; Jeney C; Pincus S; Rodeck U; Méric C; Plotkin SA; Gönczöl E
Vaccine; 1999 Jan; 17(1):50-8. PubMed ID: 10078607
[TBL] [Abstract][Full Text] [Related]
9. Human cytomegalovirus pp65 lower matrix protein: a humoral immunogen for systemic lupus erythematosus patients and autoantibody accelerator for NZB/W F1 mice.
Chang M; Pan MR; Chen DY; Lan JL
Clin Exp Immunol; 2006 Jan; 143(1):167-79. PubMed ID: 16367948
[TBL] [Abstract][Full Text] [Related]
10. Attenuated poxvirus expressing three immunodominant CMV antigens as a vaccine strategy for CMV infection.
Wang Z; La Rosa C; Lacey SF; Maas R; Mekhoubad S; Britt WJ; Diamond DJ
J Clin Virol; 2006 Mar; 35(3):324-31. PubMed ID: 16388983
[TBL] [Abstract][Full Text] [Related]
11. The next generation recombinant human cytomegalovirus vaccine candidates-beyond gB.
Lilja AE; Mason PW
Vaccine; 2012 Nov; 30(49):6980-90. PubMed ID: 23041121
[TBL] [Abstract][Full Text] [Related]
12. Optimized recombinant dense bodies of human cytomegalovirus efficiently prime virus specific lymphocytes and neutralizing antibodies without the addition of adjuvant.
Becke S; Aue S; Thomas D; Schader S; Podlech J; Bopp T; Sedmak T; Wolfrum U; Plachter B; Reyda S
Vaccine; 2010 Aug; 28(38):6191-8. PubMed ID: 20655401
[TBL] [Abstract][Full Text] [Related]
13. Refinement in the production and purification of recombinant HCMV IE1-pp65 protein for the generation of epitope-specific T cell immunity.
Nguyen TH; Mifsud NA; Stewart LA; Rose MJ; Etto TL; Williamson NA; Purcell AW; Kotsimbos T; Schwarer AP
Protein Expr Purif; 2008 Sep; 61(1):22-30. PubMed ID: 18539483
[TBL] [Abstract][Full Text] [Related]
14. Modification of the major tegument protein pp65 of human cytomegalovirus inhibits virus growth and leads to the enhancement of a protein complex with pUL69 and pUL97 in infected cells.
Becke S; Fabre-Mersseman V; Aue S; Auerochs S; Sedmak T; Wolfrum U; Strand D; Marschall M; Plachter B; Reyda S
J Gen Virol; 2010 Oct; 91(Pt 10):2531-41. PubMed ID: 20592110
[TBL] [Abstract][Full Text] [Related]
15. Optimization of DNA immunization against human cytomegalovirus.
Endrész V; Burián K; Berencsi K; Gyulai Z; Kari L; Horton H; Virok D; Méric C; Plotkin SA; Gönczöl E
Vaccine; 2001 Jul; 19(28-29):3972-80. PubMed ID: 11427273
[TBL] [Abstract][Full Text] [Related]
16. Immunogenicity evaluation of DNA vaccines that target guinea pig cytomegalovirus proteins glycoprotein B and UL83.
Schleiss MR; Bourne N; Jensen NJ; Bravo F; Bernstein DI
Viral Immunol; 2000; 13(2):155-67. PubMed ID: 10892996
[TBL] [Abstract][Full Text] [Related]
17. Combined DNA immunization with the glycoprotein gene of viral hemorrhagic septicemia virus and infectious hematopoietic necrosis virus induces double-specific protective immunity and nonspecific response in rainbow trout.
Boudinot P; Blanco M; de Kinkelin P; Benmansour A
Virology; 1998 Sep; 249(2):297-306. PubMed ID: 9791021
[TBL] [Abstract][Full Text] [Related]
18. Cell-cycle-dependent localization of human cytomegalovirus UL83 phosphoprotein in the nucleolus and modulation of viral gene expression in human embryo fibroblasts in vitro.
Arcangeletti MC; Rodighiero I; Mirandola P; De Conto F; Covan S; Germini D; Razin S; Dettori G; Chezzi C
J Cell Biochem; 2011 Jan; 112(1):307-17. PubMed ID: 21053310
[TBL] [Abstract][Full Text] [Related]
19. Vaccination of rhesus macaques against dengue-2 virus with a plasmid DNA vaccine encoding the viral pre-membrane and envelope genes.
Putnak R; Fuller J; VanderZanden L; Innis BL; Vaughn DW
Am J Trop Med Hyg; 2003 Apr; 68(4):469-76. PubMed ID: 12875299
[TBL] [Abstract][Full Text] [Related]
20. Experimental preemptive immunotherapy of murine cytomegalovirus disease with CD8 T-cell lines specific for ppM83 and pM84, the two homologs of human cytomegalovirus tegument protein ppUL83 (pp65).
Holtappels R; Podlech J; Grzimek NK; Thomas D; Pahl-Seibert MF; Reddehase MJ
J Virol; 2001 Jul; 75(14):6584-600. PubMed ID: 11413326
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
